Syncom Formulations (India) consolidated net profit rises 106.42% in the June 2025 quarter

Sales rise 33.97% to Rs 116.90 crore
Net profit of Syncom Formulations (India) rose 106.42% to Rs 15.75 crore in the quarter ended June 2025 as against Rs 7.63 crore during the previous quarter ended June 2024. Sales rose 33.97% to Rs 116.90 crore in the quarter ended June 2025 as against Rs 87.26 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var.Sales116.9087.26 34 OPM %13.5211.98 -PBDT21.5911.40 89 PBT20.2510.10 100 NP15.757.63 106Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Aug 08 2025 | 5:59 PM IST
